Superworth

Endovia Health Sciences free cash flow EDVA

Cash from operations less capital spending, by quarter and over the last twelve months, from 2015.

Last 12 months, to Dec 31, 2024
n/m
a quarter missing
Latest quarter, Q4 FY24
−$1.6M
Fiscal year 2024
n/a

Endovia Health Sciences' twelve-month free cash flow can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q4 FY24, it was −$1.6M.

Free cash flow over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearFree cash flowChange
FY2024n/an/a
FY2023−$10.2Mn/a
FY2022−$13.9Mn/a
FY2021n/an/a
FY2020−$21.4Mn/a
FY2019−$2.7Mn/a
FY2018−$13.2Kn/a
FY2017−$75.9Kn/a
FY2016−$26.3Kn/a
FY2015−$13.8Kn/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedFree cash flowOn a year earlierLast 12 months
Q4 FY24−$1.6Mn/an/a
Q1 FY24−$1.3Mn/a−$7.4M
Q4 FY23−$1.7Mn/a−$10.2M
Q3 FY23−$2Mn/a−$11.8M
Q2 FY23−$2.4Mn/a−$13.4M
Q1 FY23−$4.1Mn/a−$13.4M
Q4 FY22−$3.3Mn/a−$13.9M
Q3 FY22−$3.6Mn/a−$13.8M
Q2 FY22−$2.4Mn/an/a
Q1 FY22−$4.7Mn/an/a
Q4 FY21−$3.1Mn/an/a
Q4 FY20−$17.1Mn/a−$21.4M

Against its peers

Companies in Beverages - Non-Alcoholic nearest Endovia Health Sciences' size, closest first, today.

CompanyFree cash flow yield
EDVAEndovia Health Sciencesn/m
IPSTIP Strategy−1135.0%
AMSSAmass Brandsn/m
YHCLQR Housen/m
REEDReed'Sn/m
WVVIWillamette Valley Vineyards6.6%
SRXHSRX Globaln/m
BUDABuda Juicen/m
ZVIAZevia PBC2.9%
BRCCBRC2.7%
SUJASuja Lifen/m
Peer median2.8%

What the free cash flow tells you

Cash from operations minus capital spending. The cash the company could hand back or reinvest.

Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.

More on Endovia Health Sciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.